资讯
4 天on MSN
InflaRx Discontinues Pyoderma Gangrenosum Trial, Shifts Focus to INF904 with Summer 2025 ...
InflaRx (NASDAQ:IFRX) is one of the best penny stocks under $1 to buy now. As May came to an end, InflaRx announced that its ...
InflaRx (NASDAQ:IFRX) is one of the best penny stocks under $1 to buy now. As May came to an end, InflaRx announced that its Phase 3 trial for vilobelimab in pyoderma gangrenosum/PG would be ...
1 天
24/7 Wall St. on MSN4 High-Yield Blue-Chip Pharmaceutical Giants Offer Huge Total Return Potential
Here are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.
4 天
Great Pet Care on MSNDog Belly Rash: 6 Causes and How to Help
Concerned about a dog belly rash? Discover common causes, symptoms, and treatment options to help soothe your pup’s irritated ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果